about
Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion proteinA novel human disease with abnormal prion protein sensitive to proteaseClearance systems in the brain-implications for Alzheimer diseaseImmunotherapeutic approaches for Alzheimer's diseaseApolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloidSystematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble saltsStyryl-based and tricyclic compounds as potential anti-prion agentsAlzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics.Brain-region-specific alterations of the trajectories of neuronal volume growth throughout the lifespan in autismPreventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors.Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.Dissolution of arterial platelet thrombi in vivo with a bifunctional platelet GPIIIa49-66 ligand which specifically targets the platelet thrombusAssessment of chemokine receptor function on monocytes in whole blood: In vitro and ex vivo evaluations of a CCR2 antagonist.Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion proteinAnti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouseImmunomodulation targeting abnormal protein conformation reduces pathology in a mouse model of Alzheimer's disease.Prevalence of cognitive impairment no dementia in a rural area of Northern ChinaThe neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changesDissolution of pre-existing platelet thrombus by synergistic administration of low concentrations of bifunctional antibodies against β3 integrin.Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3Stereological study of the neuronal number and volume of 38 brain subdivisions of subjects diagnosed with autism reveals significant alterations restricted to the striatum, amygdala and cerebellumAbnormal intracellular accumulation and extracellular Aβ deposition in idiopathic and Dup15q11.2-q13 autism spectrum disordersMucosal vaccination delays or prevents prion infection via an oral route.Primary age-related tauopathy (PART): a common pathology associated with human agingPART, a distinct tauopathy, different from classical sporadic Alzheimer disease.Novel immunological approaches for the treatment of Alzheimer's disease.Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimagingImmunization treatment approaches in Alzheimer's and prion diseases.Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndromeInduction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathologyNeuronal nucleus and cytoplasm volume deficit in children with autism and volume increase in adolescents and adults.A safer vaccine for Alzheimer's disease?A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhagesIntraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degenerationTGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer CachexiaChemical Fluorescent Probe for Detection of Aβ Oligomers.Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice
P50
Q24322990-E5F0C707-B58D-46DF-AD30-1E563EE9629EQ24648865-161BC9E3-DC5D-4B20-9C6C-6356340B5445Q26801541-826C6B7B-A6CF-4893-9FFB-C884590AF292Q28081278-A780CE28-DAA1-442A-960A-38770DEF63DDQ28279517-2686453B-78CA-4B8F-A948-7410D0F56DE5Q28387541-55158B4B-C515-4906-A4E2-20180851D68CQ28740431-F5E91867-CE60-4327-B83A-02980EF26436Q28771398-6F7C5AD7-7B5B-4841-8D53-44FFFE5E068EQ30244736-72B9F994-BFBF-411F-ACFA-CFC5CD4E2430Q30577423-F01A235F-BA46-4490-BA40-7BEF08EF0D36Q30855109-EF2821AB-C11C-46B3-B833-8BF4A40C9145Q33248701-9F4DC3E4-A76F-4D76-8981-34F5FA33F200Q33389941-289C79EE-0895-475B-AC08-C87C66CC6C44Q33515938-0F21642F-DD86-47B2-A4A6-2E0098F060F6Q33576693-72A492FD-1CC7-46EF-99AF-67223ECAECD2Q33718694-266270E0-D828-4116-95D2-9DC521EF208FQ33725397-C4D3F805-A38D-4BEF-BEBD-3A5C1BC6924CQ33725397-F7E59E76-424A-47F5-97B2-BE22ED37E150Q33818750-B59317F1-AB95-4058-89B5-F99C50617B3BQ33847352-09563B00-1D25-4582-A0E9-9EA22F0F1033Q34064897-5E0D7D55-192F-46E7-9DC7-5664CDE4CCF1Q34227162-0169B468-2F39-4E21-BB5D-712401116C18Q34229659-2177FAD0-2778-4BB5-AA46-AD30DC9B1874Q34254256-5663FC41-1210-4A4B-8B34-07AAEB939EEFQ34261556-57CE277C-0F66-42C9-8240-D869BCFBED4DQ34416637-3774AB9C-1145-487C-9FCA-318327BF0401Q34445021-20CD8E8B-DE8A-48FD-8946-222CD0DD43F4Q34467464-76B92A7A-8AE4-4255-9C56-6221554CD113Q34562675-8F963064-6F36-4E7C-8848-B7C11FAFE7ABQ34611770-07420468-CEBD-4476-90F0-4EFA49E9AC0FQ34778095-85435603-6BEF-4428-8255-F7DDEC30E3BAQ34867587-F3A488FA-3C2D-4C86-BC03-D605F92E9748Q34943311-ECD9D7C8-3042-4D54-AD03-9686CCA0913DQ34998124-097B98E7-80A2-44F5-87B5-3B4606A97778Q35019424-840C0306-2A86-44EC-9A6F-231866AF4670Q35103136-4176FCD3-4374-4151-A807-9D0AFE7954A7Q35606537-50352B41-2E51-4154-9F0A-5D7A98299B2EQ35683326-60C9DD00-8E14-46EA-BB8A-4B16D1D687A0Q35690582-F60C89C8-0A0F-4BEE-90B0-606AD33C5FE0Q35719664-05A7E6C3-4BD3-4AB0-9DC6-9A0A313A6B0A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Thomas Wisniewski
@ast
Thomas Wisniewski
@en
Thomas Wisniewski
@es
Thomas Wisniewski
@nl
Thomas Wisniewski
@sl
type
label
Thomas Wisniewski
@ast
Thomas Wisniewski
@en
Thomas Wisniewski
@es
Thomas Wisniewski
@nl
Thomas Wisniewski
@sl
prefLabel
Thomas Wisniewski
@ast
Thomas Wisniewski
@en
Thomas Wisniewski
@es
Thomas Wisniewski
@nl
Thomas Wisniewski
@sl
P106
P21
P31
P496
0000-0002-3379-8966